Logotype for BellRing Brands Inc

BellRing Brands (BRBR) Q4 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for BellRing Brands Inc

Q4 2024 earnings summary

13 Jan, 2026

Executive summary

  • Fiscal 2024 net sales grew 19.8% year-over-year to $1,996.2 million, with adjusted EBITDA up 30.1% to $440.2 million, both exceeding long-term targets.

  • Premier Protein and Dymatize brands achieved record household penetration, market share, and distribution, with Premier Protein maintaining the #1 RTD market share at 23%.

  • The company is shifting from supply-constrained to demand-driven growth, with significant marketing investments planned for 2025.

  • The convenient nutrition category grew 6% year-over-year, with RTD products up 13% and RTM growth moderating.

  • Club channel returned to growth, and Premier Protein led the RTD shake category with a 23% tracked market share and record household penetration up 19% in FY24.

Financial highlights

  • Q4 net sales reached $556 million, up 18% year-over-year; adjusted EBITDA was $117 million, also up 18%.

  • Full-year net sales were just under $2 billion, up 20%; adjusted EBITDA was $440 million, up 30%, with a margin of 22.1%.

  • Q4 gross profit was $205.1 million (36.9% margin), up from $155.3 million (32.9%) year-over-year, aided by input cost deflation and production attainment fees.

  • Q4 net earnings per diluted share were $0.55, up 57.1% year-over-year; adjusted net earnings per share were $0.51, up 24.4%.

  • Fiscal 2024 SG&A expenses rose to $284.6 million (14.3% of sales), reflecting higher marketing, employee, and distribution costs.

Outlook and guidance

  • Fiscal 2025 net sales are expected to grow 12%-16% to $2.24-$2.32 billion; adjusted EBITDA is projected to grow 5%-11% to $460-$490 million.

  • Adjusted EBITDA margins are expected to decline 130 basis points to 20.8% at the midpoint, mainly due to input cost inflation and increased marketing.

  • Q1 2025 net sales growth is forecasted to exceed 20%, with Premier Protein as the main driver.

  • Capital expenditures for fiscal 2025 projected at approximately $7 million.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more